Flag EFP

27 September 2021

Systemic antibiotics ‘provide no additional benefit to non-surgical peri-implantitis treatment’

Categories: Clinical Practice, Communication

Research suggests that the use of adjunctive systemic antibiotics provides no additional benefit to the non-surgical treatment of peri-implantitis.

A randomised clinical trial, now summarised in JCP Digest 91, evaluated the effect of adjunctive systemic amoxicillin plus metronidazole on full-mouth non-surgical peri-implantitis treatment.

The research found that there was no statistically significant difference between test and control groups in terms of clinical or microbiological outcomes, although there was a tendency for some benefit from systemic antimicrobials when deep peri-implant pockets had initially been present.

Researchers concluded that the routine prescription of antibiotic therapy for the treatment of peri-implantitis should not be recommended.

The research was summarised for JCP Digest by students of the EFP-accredited postgraduate programme in periodontology, International University of Catalonia (UIC), Barcelona, Spain.


You are currently offline. Some pages or content may fail to load.